Loading clinical trials...
Loading clinical trials...
A Pilot Phase II Study To Assess The Efficacy Of Brentuximab Vedotin Administered Sequentially With ABVD Chemotherapy In Patients With Untreated Hodgkin Lymphoma.
Conditions
Interventions
Brentuximab vedotin
ABVD
Locations
3
Italy
Institute of Hematology and Medical Oncology "L. e A. Seràgnoli" at the University of Bologna
Bologna, Italy
Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia
Modena, Italy
Hematology, Azienda Ospedaliera Arcispedale S.Maria Nuova IRCCS
Reggio Emilia, Italy
Start Date
April 1, 2013
Primary Completion Date
November 1, 2013
Completion Date
March 1, 2015
Last Updated
October 27, 2014
NCT05529069
NCT06189391
NCT05006716
NCT06026319
NCT05442515
NCT06745076
Lead Sponsor
University of Modena and Reggio Emilia
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions